110 results
8-K
EX-99.1
TGTX
TG Therapeutics Inc
30 Apr 20
TG Therapeutics Bolsters Board of Directors with the Appointment of Sagar Lonial, MD
7:31am
excited to be a part of this innovative company in hopes of bringing TG’s B-cell targeted pipeline to many patients in need.”
Sagar Lonial, MD, FACP
8-K
EX-99.3
mqpibz7
9 Dec 14
Other Events
12:00am
8-K
EX-99.1
mr8ceo f1vp07587
10 Nov 14
TG Therapeutics, Inc. Announces Third Quarter 2014 Financial Results and Business Update
12:00am
8-K
EX-99.1
4ltmnrt9a1wlkh80r
15 Sep 14
Overall Response Rate (ORR) to be the Primary Endpoint to Support Accelerated Approval with Progression-Free Survival (PFS) to Support Full Approval
12:00am
8-K
EX-99.1
pn1wmkfz
21 Jul 14
Other Events
12:00am
8-K
EX-99.1
7btkoowq773cdw
21 Jul 14
TG Therapeutics, Inc. Announces Second Quarter 2014 Financial Results and Business Update
12:00am
8-K
EX-99.1
mx771fermunsfa0zhr2
30 May 14
TG Therapeutics, Inc. Announces Presentation of Single Agent Data for Both TG-1101 and TGR-1202 in Ongoing Phase I Clinical Studies
12:00am
424B5
1npux2 w8w9hvr0sw7
12 Mar 14
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
1uotmi43nw
6 Mar 14
TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results and Business Update
12:00am
8-K
EX-99.1
itb8hivva wyaf614s
11 Dec 13
TG Therapeutics, Inc. Announces Presentation of Encouraging Clinical Activity of TGR-1202 in an Ongoing Multi-center Phase I Clinical Study
12:00am
8-K
EX-99.1
wo9tfta43615eo g2vk
29 Oct 13
Other Events
12:00am